Gilead Sciences has made another foray into the natural killer (NK) cell category, paying $300 million upfront to access Dragonfly Therapeutics' TriNKET platform to find therapies for cancer and ...

Bristol-Myers Squibb has signed an agreement worth $475 million to develop a new form of cancer immunotherapy drug with US biotech Dragonfly Therapeutics. BMS is best known as an early pioneer of ...

James Chen, CMT is an expert trader, investment adviser, and global market strategist. Somer G. Anderson is CPA, doctor of accounting, and an accounting and finance professor who has been working in ...

Since 2004, Tires Easy has revolutionized the tire-buying experience for thousands across the Continental U.S. Imagine premium-quality tires delivered right to your doorstep or your chosen local ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Sign up now for the latest news from Australia and around the world direct to your inbox.

Qrepo is a lightweight and intuitive package and build manager designed to streamline the process of managing project dependencies and scripts. Whether you're working on a small script or a complex ...